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Abstract
Introduction. Sometimes it is not easy to clinically recognize
subtle differences between intraocular lymphoma and non-
infectious uveitis. The most common lymphoma subtype in-
volving the eye is B-cell lymphoma. Case report. We pre-
sented two patients aged 59 and 58 years with infiltration of
the subretinal space with a large B-cell non-Hodgkin intra-
ocular lymphoma. The patients originally had clinically
masked syndrome in the form of intermediate uveitis. As it
was a corticosteroid-resistant uveitis, we focused on the pos-
sible diagnosis of neoplastic causes of this syndrome. During
hospitalization, the neurological symptoms emerged and
multiple subretinal changes accompanied by yellowish white
patches of retinal pigment epithelium with signs of vitritis,
which made us suspect the intraocular lymphoma. Endocra-
nial magnetic resonance imaging established tumorous infil-
tration in the region of the left hemisphere of the cerebellum.
The histopathological finding confirmed the diagnosis of
large B-cell non-Hodgkin lymphoma of risk moderate degree,
immunoblast – centroblast cytological type. The other patient
had clinical chronic uveitis accompanied by yellowish shaped
white echographic changes of the retina and localized changes
in the level of the subretina. The diagnosis of lymphoma was
made by brain biopsy. Conclusion. Uveitis masquerade syn-
drome should be considered in all patients over 40 years with
idiopathic steroid-resistant uveitis. Treatment begun on time
can affect the course and improve the prognosis of uveitis
masquerade syndrome (UMS) and systemic disease.
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Apstrakt
Uvod. Ponekad je teško ustanoviti suptilnu razlika izmeĀu
intraokularnog limfoma i neinfektivnog uveitisa. Najÿešýi
podtip intraokularnog limfoma je B-ýelijski limfom. Prikaz
bolesnika. Prikazali smo dva bolesnika, starosti 59 i 58 go-
dina, sa infiltracijom subretinalnog prostora velikim B-
ýelijama non-Hodgkin itraokularnog limfoma. Prvi bolesnik
prvobitno je imao kliniÿku sliku maskiranog sindoma u vidu
intermedijalnog uveitisa. Kako se radilo o kortikosteroid-
rezistentnom uveitisu, usredsredili smo se na moguýu dijag-
nozu neoplastiÿnog uzroka ovog maskiranog sindroma. U
toku hospitalizacije na neurologiji pojavili su se subretinalni
eksudati praýeni žuýkastobeliÿastim promenama retinalnog
pigmentnog epitela i znacima vitritisa koji su nas naveli na
sumnju na intraokularni limfom. Magnetna rezonanca (MR)
endokranijuma potvdila je infiltraciju leve hemisfere cere-
beluma. Patohistološki nalaz operisanog tumora cerebeluma
potvrdio je dijagnozu non-Hodgkin limfoma velikih B-ýelija,
umerenog stepena rizika, imunoblast-centroblastom citološ-
kog tipa. Drugi bolesnika imao je kliniÿku sliku hroniÿnog
zadnjeg uveitisa sa žuýkasto beliÿastim promenama retine i
ehografski lokalizovanim promenama u nivou subretine.
Dijagnoza limfoma postavljena je biopsijom mozga. Zak-
ljuÿak. Uveitis maskirani sindom (UMS) treba razmotriti
kod svih bolesnika starijih od 40 godina sa idiopatskim kor-
tikosteroid-rezistentnim uveitisom. Leÿenje zapoÿeto na
vreme može uticati na tok i poboljšati prognozu UMS i sis-
temske bolesti.
Kljuÿne reÿi:
oko, neoplazme; limfom, nehodžkinov; uveitis;
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Introduction
Uveitis masquerade syndromes (UMSs) are a group of
non-inflammatory ocular diseases of benign or malign ori-
gin 
1, 2. A neoplastic lesion causes intraocular cellular infil-
tration and mimics intraocular inflammation, simulating im-
mune mediated uveitis, poorly or not at all responsive to
corticosteroid treatmant. Because UMSs are not only sight-
threatening but in case of malign UMSs also a life-
threatening disease,  prompt and correct diagnosis and treat-
ment is very important 
3.
The World Health Organization (WHO) / Revised
European-American Classification of Lymphoid Neoplasms
(REAL) immunophenotypic classification identifies 3 types
of lymphomas: B-cell neoplasms, T-cell and natural killer
(NK) cell neoplasms and Hodgkin's disease 
4.
Intraocular lymphoma can be further classified either as
primary B-cell lymphoma of the retina and central nervous
system (CNS) or as extranodal lymphoma of the uvea, or as a
secondary B-cell lymphoma that represents uveal manifesta-
tion of systemic lymphoma. The most common lymphoma
subtype involving the eye is B-cell lymphoma 
4. Suspicion is
needed if symptoms are uniteral or occurs in very young
children or in the elderly.
Primary intraocular lymphoma (PIOL) is, in fact, a
subtype of primary central nervous system lymphoma
(PCNSL) and non-Hodgkin's lymphoma (NHL). Neuraxis
consists of not only the brain and spinal cord, but also the
neurosensory retina. PCNSL is most commonly a B-cell tu-
mor, though T-cell PCNSL has been described
 4. As an NHL
B-cell disease, PCNLS is most frequently a subtype of dif-
fuse large B-cell lymphoma (DLBCL).
There are 3 major subtypes of DLBCL: activated B-cell
DLBCL (ABC DLBCL), germinal center B-cell (GCB
DLBCL), and primary mediastinal (thymic large) B-cell
DLBCL (PMB DLBCL) also known as type 3, based on
gene signature profiling
 5.
Ocular disease is bilateral in 50% of patients with
PIOL
 6 . Differential diagnosis include various diseases,
such as sarcoidasis, tuberculosis, syphilis, toxophamosis,
toxocardiasis, idiopathic vasculitis and scleritis, primary
ocular – CNS non Hodgkins lymphoma, large B cell lym-
phoma, etc.
This small, retrospective observation case study reports
the clinical presentation and pathophysiologic correlation in
2 patients over 50 years of age with masquerade syndrome.
Informed consent was obtained from each patient.
Comprehensive clinical ophthalmic examination using
ultrasound and fluorescein angiography diagnostics was per-
formed in both patients, who were further evaluated with
computed topography (CT) and magnetic resonance imaging
(MRI). All imaging modalities were conducted according to
the standard protocol
 7 . The diagnosis of intraocular lym-
phoma was based on the histopathology pattern on biopsy
spacemen
 8.
Case report 1
The first patient, a 59-year-old man, presented with an
11-month history of intraocular inflammation like uveitis,
anterior and posterior. He had no ophthalmological disease
in the past. The first ophthalmological manifestations were in
the form of unilateral anterior and then posterior uveitis fol-
lowed changes developed later in the same sense and on the
other eye. The front uveitis was a small whitish precipitate of
the endothel without plastic reactions in the sense of creating
synechia. Posterior uveitis was in the form of vitritis with
creamy white lesions in the level of the retina and retinal
pigment epithelium (RPE) lesion boundary (Figure 1a).
The findings of ultrasound a month after showed lifting
of the retinas in both eyes with masses in the subretinal space
(Figures 1b and c).
Visual acuity and field of vision were changed. Initially
the patient only slightly reacted to the corticosteroid therapy.
After a year from the first appearance of symptoms of uveitis
the patient developed neurological manifestations of the dis-
ease but still the CT finding was negative.
The third attempt with MRI detected tumor in the left
hemisphere of the cerebellum.  Pathohistological findings
showed a diffuse large B-cell non-Hodgkin lymphoma of a
moderate degree risk, immunoblast-centroblast cytological
type. A diffuse large cell tumor consisted of large oval or ir-
regular cell nuclei, with a large nucleolus and a lower num-
ber of smaller, medium or heavy amphophil basophil cyto-
plasm, with a rare presence of apoptosis, with a tangible
body macrophage histiocytoma and numerous mitoses (Fig-
ure 1d).
 a) b) c) d)
Fig. 1 – A patient with primary intraocular lymphoma showing creamy white lesions at the level of the retina and retinal
pigment epithelium lesion boundary.
a) Fotofundus; b, c) Ultrasound – lifting of the retinas in both eyes with masses in the subretinal space; d) Non-Hodgkin lymphoma in the
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He was afebrile and his routine blood test was normal
except low total red blood cell count (RBC), hemoglobin
(Hgb), mean platelet volume (MPV) and relative volume of
thrombocytes (Pct) were on little level. The patient did not
allow biopsy of the retina.
Localization of the tumor was in the brain and subreti-
nal space, actually in the immune privileged sites.
Case report 2
The second patient was a 58-year-old woman with ante-
rior and posterior uveitis for several months. She showed no
satisfactory respond to the treatment with corticosteroids. In
fact, the therapy with corticosteroids had led to an incom-
plete reabsorption flare and precipitate in the front segment,
with signs of vitritis in the back. The last segment was visi-
ble and the ultrasound findings showed an improvement. The
posterior uveitis was manifested in the form of creamy, yel-
low white to orange subretinal pigment epithel (RPE) infil-
trates, which also disappeared as a result of the treatment
with corticosteroids, but the last segment as a whole was
changed (Figure 2a).
Ultrasound suggested that intraocular lymphoma still
responded to corticosteroid therapy. The fluorescein angiog-
raphy in the intraocular lymphoma had a characteristic ap-
pearance. RPE disturbances included granularity, mottling,
and late staining patterns. Fluorescence blockage at the level
of the RPE, due to tumor infiltration could correspond to the
deep retinal or subretinal creamy colored lesions noted on
fundus photography. Visual acuity and visual field testing,
were both reduced significantly. Intraocular (IOP) was 14
mm Hg. A routine blood test was normal except for Hgb.
MR images demonstrated enhancement in the left temporal
lobe. The diagnosis of lymphoma was made by brain biopsy.
Histopathological finding was diffuse large B-cell non-
Hodgkin lymphoma (Figures 2 b, c and d).
Discussion
Primary intraocular lymphoma is the most common
manifestation of masked uveitis syndromes
 9. It is typically
presented as posterior uveitis with cellular exudation in the
vitreous fluid
 10. Imaging of the eye is the first step in evalu-
ating the diagnosis with suspicion of PIOL. The role of an
ophthalmologist is particularly important. Imaging of the
central nervous system should be included. Imaging modali-
ties are: full field fundus photography, ultrasound, fluores-
cein angiography, indocyanine green angiography, ocular
coherence tomography, brain imaging. Systemic organs im-
aging is generally not necessary in the cases of suspected
PIOL or PCNSL, and this practice is not highly recom-
mended 
11. When there is a reason to suspect systemic lym-
phoma added to the standard tests are a complete blood cell
count, erythrocyte sedimentation rate, and bone marrow
evaluation 
12. Vitreous biopsy is a useful tool to diagnose
PIOL. If it is implemented prior to steroid therapy, it might
suppress the number of vitreous cells, including lymphoma
cells, which may result in a negative vitreous cytology 
13. The
lymphoma cells of POIL and PCNSL are very fragile, and if
systemic corticosteroids are used to treat a presumed "uveitis",
the lymphoma cells may be even more fragile 
14. Conventional
ocular and brain examination includes cytological and his-
tological examination (macroscopic and microscopic). Mo-
lecular pathology involves gene rearrangements, transloca-
tions, molecular signals, infectious deoxyribonucleic acid
(DNA) 
15. Immunohistochemistry shows the same picture as
that for PIOL. As the majority of PCNSL cells are B-cells,
they stain for CD19, CD20, and surface immunoglobulin 
16, 17.
Conclusion
Sometimes, uveitis is the only initial manifestation of
an occult systemic problem in patients older than 40 years.
UMS should be considered in all patients with idiopathic
corticosteroid resistant chronic uveitis. Primary intraocular
lymphoma should be considered in all patients aged 40 and
older with ultrasonographic findings of subretinal lesions and
vitreous cells. Malignancies and other diseases should be
considered, with implementation of diagnosis biopsies of vi-
trous fluid and brain. Timely treatment may improve the
prognosis of UMS. Direct treatment of malignancy or un-
derlying condition may be required to control uveitis.
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a) b) c) d)
Fig. 2 – A patient with primary intraocular lymphoma showing creamy, yellow-white to orange sub-retinal pigment
epithelium infiltrates
a) Fotofundus; b) Ultrasound – lifting of the retinas in both eyes with masses in the subretinal space before the therapy c) after the therapy;
d) Non-Hodgkin lymphoma in the brain (B-cell, large cell diffusum).Strana 1154 VOJNOSANITETSKI PREGLED Volumen 70, Broj 12
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